This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Epigenomics and its collaboration with Roche was profiled in Pharmaceutical & Diagnostic Innovation 2004; 5 (2): 51–5.
The study was published in the Journal of Clinical Oncology 2006; 24 (2): 252–8.
Epigenomics. Epigenomics successfully completes biomarker validation study for prostate cancer classification test. Media release: 4 Jan 2006
European Biotechnology. Epigenomics AG: change of price target. New York: Lehman Brothers Global Equity Research, 2005
Epigenomics. Epigenomics DNA methylation test successfully detects colorectal cancer in blood. Media release: 19 Dec 2005
Iceland Genomics. EU consortium POLYGENE led by Iceland Genomics Corporation Receives a 3M € grant from the 6th Framework Programme to study inherited risk of breast and prostate cancer. Media release: 19 Dec 2005
Immunomedics. New diagnostic assay for pancreatic cancer reported in Journal of Clinical Oncology. Media release: 16 Dec 2005
MedMira. MedMira receives CE Mark for MiraCare Rapid HIV Test; Europeans now have access to first instant rapid HIV test. Media release: 17 Jan 2006
MedMira. MedMira granted hepatitis C patent in Europe; Patent further protects MedMira’s diagnostic technology. Media release: 3 Jan 2006
CeMines. CeMines® granted European Union regulatory clearance and CE Mark registration of its Cell Correct LAb® clinical Dx test for lung cancer. Media release: 11 Jan 2006
Tm Bioscience. Tm Bioscience cystic fibrosis test now has CE mark. Media release: 11 Jan 2006